3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Esophageal Squamous Cell Carcinoma
1
Interventions
Cisplatin
45
Radiotherapy
32
Fluorouracil
27
Paclitaxel
26
Irinotecan
17
Docetaxel
16
Oxaliplatin
11
Carboplatin
10
pembrolizumab
9
Cetuximab
8
tislelizumab
7
Surgical Procedures, Operative
7
Neoadjuvant Therapy
7
Drug Therapy
7
Radiation
6
Leucovorin
6
sintilimab
5
Nivolumab
5
Immunohistochemistry
5
Chemotherapy, Adjuvant
5
Capecitabine
5
nedaplatin
3
durvalumab
3
camrelizumab
3
S 1 (combination)
3
Magnetic Resonance Spectroscopy
3
Gene Expression Profiling
3
Gemcitabine
3
Fluorodeoxyglucose F18
3
Erlotinib Hydrochloride
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Esophageal Squamous Cell Carcinoma
×
Andrographis paniculata extract
×
Clear all
NCT04196075
2021-11-08
AP
Chinese University of Hong Kong
Phase 3
Completed
30 enrolled